Papers
2024
Bagchi S, Yuan R, Huang HL, Zhang W, Chiu DK, Kim H, Cha SL, Tolentino L, Lowitz J, Liu Y, Moshnikova A, Andreev O, Plevritis S, Engleman EG. The acid-sensing receptor GPR65 on tumor macrophages drives tumor growth in obesity. Sci Immunol. 2024, 9(100), eadg6453. PubMed
Moshnikova A, DuPont M, Iraca M, Klumpp C, Visca H, Allababidi D, Pelzer P, Engelman DM, Andreev OA, Reshetnyak YK. Targeted intracellular delivery of dimeric STINGa by two pHLIP peptides for treatment of solid tumors. Front Pharmacol. 2024, 15, 1346756. PubMed
Ye Q, Jo J, Wang CY, Oh H, Zhan J, Choy TJ, Kim KI, D’Alessandro A, Reshetnyak YK, Jung SY, Chen Z, Marrelli SP, Lee HK. Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a CCL2-CCR2 pathway and NO dysregulation. Cell Rep. 2024, 43(5), 114193 PubMed
Reshetnyak, Yana K., Oleg A. Andreev, and Donald M. Engelman. Aiming the Magic Bullet: Targeted Delivery of Imaging and Therapeutic Agents to Solid Tumors by pHLIP Peptides. Frontiers in Pharmacology, 2024, 15, 1355893. Pubmed
DuPont M, Klumpp C, Iraca M, Allababidi D, Visca H, Engelman DM, Andreev OA, Moshnikova A, Reshetnyak YK. pHLIP targeted intracellular delivery of calicheamicin. Int J Pharm. 2024, 654, 123954. PubMed
2023
Matsui, Toma, Yuki Toda, Haruka Sato, Rina Itagaki, Kazuya Konishi, Anna Moshnikova, Oleg A. Andreev, Shigekuni Hosogi, Yana K. Reshetnyak, and Eishi Ashihara. “Targeting acidic pre-metastatic niche in lungs by pH Low Insertion Peptide and its utility for anti-metastatic therapy. Frontiers in Oncology 2023, 13, 1258442. PubMed
Silva TFD, Visca H, Klumpp C, Andreev OA, Reshetnyak YK, Machuqueiro M. Arginine Residues Modulate the Membrane Interactions of pHLIP Peptides. J Chem Inf Model. 2023, 63(14), 4433-4446. PubMed
DuPont M, Visca H, Moshnikova A, Engelman DM, Reshetnyak YK, Andreev OA. Tumor Treatment by pHLIP-Targeted Antigen Delivery. Front. Bioeng. Biotechnol. 2023, 10, 1082290. PubMed
2022
Moshnikova A, DuPont M, Visca H, Engelman DM, Andreev OA, Reshetnyak YK. Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP. Front Oncol. 2022, 12, 1023959. PubMed
Moshnikova A, Golijanin B, Amin A, Doyle J, Kott O, Gershman B, DuPont M, Li Y, Lu X, Engelman DM, Andreev OA, Reshetnyak YK and Golijanin D (2022) Targeting bladder urothelial carcinoma with pHLIP-ICG and inhibition of urothelial cancer cell proliferation by pHLIP-amanitin. Front. Urol., 2022, 2, 868919. PubMed
Visca H, DuPont M, Moshnikova A, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK. pHLIP Peptides Target Acidity in Activated Macrophages. Mol Imaging Biol. 2022, 24(6), 874-885. PubMed
Bauer D, Visca H, Weerakkody A, Carter LM, Samuels Z, Kaminsky S, Andreev OA, Reshetnyak YK, Lewis JS. PET Imaging of Acidic Tumor Environment With 89Zr-labeled pHLIP Probes. Front Oncol. 2022, 12, 882541. PubMed
Zhang X, Rotllan N, Canfrán-Duque A, Sun J, Toczek J, Moshnikova A, Malik S, Price NL, Araldi E, Zhong W, Sadeghi MM, Andreev OA, Bahal R, Reshetnyak YK, Suárez Y, Fernández-Hernando C. Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression. Circ Res. 2022, 101161CIRCRESAHA121320296. PubMed
Hulikova A, Park KC, Loonat AA, Gunadasa-Rohling M, Curtis MK, Chung YJ, Wilson A, Carr CA, Trafford AW, Fournier M, Moshnikova A, Andreev OA, Reshetnyak YK, Riley PR, Smart N, Milne TA, Crump NT, Swietach P. Alkaline nucleoplasm facilitates contractile gene expression in the mammalian heart. Basic Res Cardiol. 2022, 117(1), 17. PubMed
2021
Miska J, Rashidi A, Lee-Chang C, Gao P, Lopez-Rosas A, Zhang P, Burga R, Castro B, Xiao T, Han Y, Hou D, Sampat S, Cordero A, Stoolman JS, Horbinski CM, Burns M, Reshetnyak YK, Chandel NS, Lesniak MS. Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma. Sci Adv. 2021, 7(8), eabc8929. PubMed
Gayle S, Aiello R, Leelatian N, Beckta JM, Bechtold J, Bourassa P, Csengery J, Maguire RJ, Marshall D, Sundaram RK, Van Doorn J, Jones K, Moore H, Lopresti-Morrow L, Paradis T, Tylaska L, Zhang Q, Visca H, Reshetnyak YK, Andreev OA, Engelman DM, Glazer PM, Bindra RS, Paralkar VM. Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity. NAR Cancer. 2021, 3(2), zcab021. PubMed
Wilson AD, Richards MA, Curtis MK, Rohling M, Monterisi S, Loonat AA, Miller J, Ball V, Lewis A, Tyler D, Moshnikova A, Andreev OA, Reshetnyak YK, Carr C, Swietach P. Acidic environments trigger intracellular H+-sensing FAK proteins to re-balance sarcolemmal acid-base transporters and auto-regulate cardiomyocyte pH. Cardiovasc Res. 2021, cvab364. PubMed
2020
Wu H, Estrella V, Beatty M, Abrahams D, El-Kenawi A, Russell S, Ibrahim-Hashim A, Longo DL, Reshetnyak YK, Moshnikova A, Andreev OA, Luddy K, Damaghi M, Kodumudi K, Pillai SR, Enriquez-Navas P, Pilon-Thomas S, Swietach P, Gillies RJ. T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nat Commun. 2020, 11(1), 4113. PubMed
Crawford T, Moshnikova A, Roles S, Weerakkody D, DuPont M, Carter LM, Shen J, Engelman DM, Lewis JS, Andreev OA, Reshetnyak YK. pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery. Sci Rep. 2020, 10(1), 18356. PubMed
Slaybaugh G, Weerakkody D, Engelman DM, Andreev OA, Reshetnyak YK. Kinetics of pHLIP peptide insertion into and exit from a membrane. Proc Natl Acad Sci U S A. 2020, 117(22), 12095-12100. PubMed
Henry KE, Chaney AM, Nagle VL, Cropper HC, Mozaffari S, Slaybaugh G, Parang K, Andreev OA, Reshetnyak YK, James ML, Lewis JS. Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide. J Nucl Med. 2020, 61(9), 1361-1368. PubMed
Reshetnyak YK, Moshnikova A, Andreev OA, Engelman DM. Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding. Front Bioeng Biotechnol. 2020, 8, 335. PubMed
Brito J, Golijanin B, Kott O, Moshnikova A, Mueller-Leonhard C, Gershman B, Andreev OA, Reshetnyak YK, Amin A, Golijanin D. Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel pH Low Insertion Peptide (Variant 3), a Molecular Imaging Probe. Urology. 2020, 139, 134-140. PubMed
2019
Sahraei M, Chaube B, Liu Y, Sun J, Kaplan A, Price NL, Ding W, Oyaghire S, García-Milian R, Mehta S, Reshetnyak YK, Bahal R, Fiorina P, Glazer PM, Rimm DL, Fernández-Hernando C, Suárez Y. Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response. J Clin Invest. 2019, 129(12), 5518-5536. PubMed
Price NL, Miguel V, Ding W, Singh AK, Malik S, Rotllan N, Moshnikova A, Toczek J, Zeiss C, Sadeghi MM, Arias N, Baldán Á, Andreev OA, Rodríguez-Puyol D, Bahal R, Reshetnyak YK, Suárez Y, Fernández-Hernando C, Lamas S. Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis. JCI Insight. 2019, 4(22), e131102. PubMed
Roberts S, Strome A, Choi C, Andreou C, Kossatz S, Brand C, Williams T, Bradbury M, Kircher MF, Reshetnyak YK, Grimm J, Lewis JS, Reiner T. Acid specific dark quencher QC1 pHLIP for multi-spectral optoacoustic diagnoses of breast cancer. Sci Rep. 2019, 9(1), 8550. PubMed
Wei D, Engelman DM, Reshetnyak YK, Andreev OA. Mapping pH at Cancer Cell Surfaces. Mol Imaging Biol. 2019, 21(6), 1020-1025. PubMed
2018
Rinaldi F, Hanieh PN, Del Favero E, Rondelli V, Brocca P, Pereira MC, Andreev OA, Reshetnyak YK, Marianecci C, Carafa M. Decoration of Nanovesicles with pH (Low) Insertion Peptide (pHLIP) for Targeted Delivery. Nanoscale Res Lett. 2018, 13(1), 391. PubMed
Karabadzhak AG, Weerakkody D, Deacon J, Andreev OA, Reshetnyak YK, Engelman DM. Bilayer Thickness and Curvature Influence Binding and Insertion of a pHLIP Peptide. Biophys J. 2018, 114(9), 2107-2115. PubMed
Vila-Viçosa D, Silva TFD, Slaybaugh G, Reshetnyak YK, Andreev OA, Machuqueiro M. Membrane-Induced p Ka Shifts in wt-pHLIP and Its L16H Variant. J Chem Theory Comput. 2018, 14(6), 3289-3297. PubMed
Wyatt LC, Moshnikova A, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors. Proc Natl Acad Sci U S A. 2018, 115(12), E2811-E2818. PubMed
2017
Daniels JL, Crawford TM, Andreev OA, Reshetnyak YK. Synthesis and characterization of pHLIP® coated gold nanoparticles. Biochem Biophys Rep. 2017, 10, 62-69. PubMed
Wyatt LC, Lewis JS, Andreev OA, Reshetnyak YK, Engelman DM. Applications of pHLIP Technology for Cancer Imaging and Therapy. Trends Biotechnol. 2017, 35, 653-664. PubMed
2016
Narayanan T, Weerakkody D, Karabadzhak AG, Anderson M, Andreev OA, Reshetnyak YK. pHLIP Peptide Interaction with a Membrane Monitored by SAXS. J Phys Chem B. 2016, 120(44), 11484-11491. PubMed
Pereira MC, Pianella M, Wei D, Moshnikova A, Marianecci C, Carafa M, Andreev OA, Reshetnyak YK. pH-sensitive pHLIP® coated niosomes. Mol Membr Biol. 2016, 33(3-5), 51-63. PubMed
Weerakkody D, Andreev OA, Reshetnyak YK. Insertion into lipid bilayer of truncated pHLIP® peptide. Biochem Biophys Rep. 2016, 8, 290-295. PubMed
Golijanin J, Amin A, Moshnikova A, Brito JM, Tran TY, Adochite RC, Andreev GO, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK, Golijanin D. Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo. Proc Natl Acad Sci U S A. 2016, 113(42), 11829-11834. PubMed
Weerakkody D, Moshnikova A, El-Sayed NS, Adochite RC, Slaybaugh G, Golijanin J, Tiwari RK, Andreev OA, Parang K, Reshetnyak YK. Novel pH-Sensitive Cyclic Peptides. Sci Rep. 2016, 6, 31322. PubMed
1: Demoin DW, Wyatt LC, Edwards KJ, Abdel-Atti D, Sarparanta M, Pourat J, Longo VA, Carlin SD, Engelman DM, Andreev OA, Reshetnyak YK, Viola-Villegas N, Lewis JS. PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study. Bioconjug Chem. 2016, 27(9), 2014-23. PubMed
Anderson M, Moshnikova A, Engelman DM, Reshetnyak YK, Andreev OA. Probe for the measurement of cell surface pH in vivo and ex vivo. Proc Natl Acad Sci U S A. 2016, 113(29), 8177-81. Pubmed
Shrestha S, Cooper LN, Andreev OA, Reshetnyak YK, Antosh MP. Gold Nanoparticles for Radiation Enhancement in Vivo. Jacobs J Radiat Oncol. 2016, 3(1), 026. Pubmed
Adochite RC, Moshnikova A, Golijanin J, Andreev OA, Katenka NV, Reshetnyak YK. Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP® Peptides) Conjugated with Different Fluorescent Dyes. Mol Imaging Biol. 2016, 18(5), 686-96. PubMed
2015
Tapmeier TT, Moshnikova A, Beech J, Allen D, Kinchesh P, Smart S, Harris A, McIntyre A, Engelman DM, Andreev OA, Reshetnyak YK, Muschel RJ. The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions. Proc Natl Acad Sci U S A. 2015, 112(31), 9710-5. PubMed
Reshetnyak YK. Imaging Tumor Acidity: pH-Low Insertion Peptide Probe for Optoacoustic Tomography. Clin Cancer Res. 2015, 21(20), 4502-4. PubMed
Sharma GP, Reshetnyak YK, Andreev OA, Karbach M, Müller G. Coil-helix transition of polypeptide at water-lipid interface. J Stat Mech. 2015, P01034. PubMed
Pereira MC, Reshetnyak YK, Andreev OA. Advanced targeted nanomedicine. J Biotechnol. 2015, 202, 88-97. PubMed
Antosh MP, Wijesinghe DD, Shrestha S, Lanou R, Huang YH, Hasselbacher T, Fox D, Neretti N, Sun S, Katenka N, Cooper LN, Andreev OA, Reshetnyak YK. Enhancement of radiation effect on cancer cells by gold-pHLIP. Proc Natl Acad Sci U S A. 2015, 112(17), 5372-6. PubMed
2014
Karabadzhak AG, An M, Yao L, Langenbacher R, Moshnikova A, Adochite RC, Andreev OA, Reshetnyak YK, Engelman DM. pHLIP-FIRE, a cell insertion-triggered fluorescent probe for imaging tumors demonstrates targeted cargo delivery in vivo. ACS Chem Biol. 2014, 9(11), 2545-53. PubMed
Adochite RC, Moshnikova A, Carlin SD, Guerrieri RA, Andreev OA, Lewis JS, Reshetnyak YK. Targeting breast tumors with pH (low) insertion peptides. Mol Pharm. 2014, 11(8), 2896-905. PubMed
Andreev OA, Engelman DM, Reshetnyak YK. Targeting diseased tissues by pHLIP insertion at low cell surface pH. Front Physiol. 2014, 5, 97. PubMed
Cruz-Monserrate Z, Roland CL, Deng D, Arumugam T, Moshnikova A, Andreev OA, Reshetnyak YK, Logsdon CD. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep. 2014, 4, 4410. PubMed
Viola-Villegas NT, Carlin SD, Ackerstaff E, Sevak KK, Divilov V, Serganova I, Kruchevsky N, Anderson M, Blasberg RG, Andreev OA, Engelman DM, Koutcher JA, Reshetnyak YK, Lewis JS. Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. Proc Natl Acad Sci U S A. 2014, 111(20), 7254-9. PubMed
2013
Weerakkody D, Moshnikova A, Thakur MS, Moshnikova V, Daniels J, Engelman DM, Andreev OA, Reshetnyak YK. Family of pH (low) insertion peptides for tumor targeting. Proc Natl Acad Sci U S A. 2013, 110(15), 5834-9. PubMed
Yao L, Daniels J, Wijesinghe D, Andreev OA, Reshetnyak YK. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells. J Control Release. 2013, 167(3), 228-37. PubMed
Moshnikova A, Moshnikova V, Andreev OA, Reshetnyak YK. Antiproliferative effect of pHLIP-amanitin. Biochemistry. 2013, 52(7), 1171-8. PubMed
Sosunov EA, Anyukhovsky EP, Sosunov AA, Moshnikova A, Wijesinghe D, Engelman DM, Reshetnyak YK, Andreev OA. pH (low) insertion peptide (pHLIP) targets ischemic myocardium. Proc Natl Acad Sci U S A. 2013, 110(1), 82-6. PubMed
Yao L, Daniels J, Moshnikova A, Kuznetsov S, Ahmed A, Engelman DM, Reshetnyak YK, Andreev OA. pHLIP peptide targets nanogold particles to tumors. Proc Natl Acad Sci U S A. 2013, 110(2), 465-70. PubMed
Wijesinghe D, Arachchige MC, Lu A, Reshetnyak YK, Andreev OA. pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis. Sci Rep. 2013, 3, 3560. PubMed
2012
Reshetnyak YK, Prudence CN, Segala J, Markin VS, Andreev OA. Parking problem and negative cooperativity of binding of myosin subfragment 1 to F-actin. Biochem Biophys Res Commun. 2012, 425(4), 746-9. PubMed
Daumar P, Wanger-Baumann CA, Pillarsetty N, Fabrizio L, Carlin SD, Andreev OA, Reshetnyak YK, Lewis JS. Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjug Chem. 2012, 23(8), 1557-66. PubMed
Karabadzhak AG, Weerakkody D, Wijesinghe D, Thakur MS, Engelman DM, Andreev OA, Markin VS, Reshetnyak YK. Modulation of the pHLIP transmembrane helix insertion pathway. Biophys J. 2012, 102(8), 1846-55. PubMed
Macholl S, Morrison MS, Iveson P, Arbo BE, Andreev OA, Reshetnyak YK, Engelman DM, Johannesen E. In vivo pH imaging with (99m)Tc-pHLIP. Mol Imaging Biol. 2012, 14(6), 725-34. PubMed
2011
Barrera FN, Weerakkody D, Anderson M, Andreev OA, Reshetnyak YK, Engelman DM. Roles of carboxyl groups in the transmembrane insertion of peptides. J Mol Biol. 2011, 413(2), 359-71. PubMed
Reshetnyak YK, Yao L, Zheng S, Kuznetsov S, Engelman DM, Andreev OA. Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP. Mol Imaging Biol. 2011, 13(6), 1146-56. PubMed
Wijesinghe D, Engelman DM, Andreev OA, Reshetnyak YK. Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide. Biochemistry. 2011, 50(47), 10215-22. PubMed
2010
An M, Wijesinghe D, Andreev OA, Reshetnyak YK, Engelman DM. pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. Proc Natl Acad Sci U S A. 2010, 107(47), 20246-50. PubMed
Andreev OA, Karabadzhak AG, Weerakkody D, Andreev GO, Engelman DM, Reshetnyak YK. pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proc Natl Acad Sci U S A. 2010, 107(9), 4081-6. PubMed
Andreev OA, Engelman DM, Reshetnyak YK. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents. Mol Membr Biol. 2010, 27(7), 341-52. PubMed
Musial-Siwek M, Karabadzhak A, Andreev OA, Reshetnyak YK, Engelman DM. Tuning the insertion properties of pHLIP. Biochim Biophys Acta. 2010, 1798(6), 1041-6. PubMed
Yao L, Segala J, Bucci AJ, Andreev GO, Reshetnyak YK, Andreev OA. Fluorescence anistropy imaging microscopy. Microscopy: Science, Technology, Applications and Education, Formatex Research Center, 2010, 3, 2072-8. ResearchGate
2009
Andreev OA, Engelman DM, Reshetnyak YK. Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP). Chim Oggi. 2009, 27(2), 34-37. PubMed
Hixon J, Reshetnyak YK. Algorithm for the Analysis of Tryptophan Fluorescence Spectra and Their Correlation with Protein Structural Parameters. Algorithms 2009, vol. 2: 1155-76. Journal
Segala J, Engelman DM, Reshetnyak YK, Andreev OA. Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP). Int J Mol Sci. 2009, 10(8), 3478-87. PubMed
Vāvere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res. 2009, 69(10), 4510-6. PubMed
Yao L, Andreev GO, Reshetnyak YK, Andreev OA. Fabrication of semiconductor nanowires by conjugation of quantum dots to actin filaments. Anal Bioanal Chem. 2009, 395(5), 1563-6. PubMed
2008
Jain N, Reshetnyak YK, Gao L, Chiarelli MP, Cho BP. Fluorescence probing of aminofluorene-induced conformational heterogeneity in DNA duplexes. Chem Res Toxicol. 2008, 21(2), 445-52. PubMed
Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc Natl Acad Sci U S A. 2008, 105(40), 15340-5. PubMed
Shen C, Menon R, Das D, Bansal N, Nahar N, Guduru N, Jaegle S, Peckham J, Reshetnyak YK. The protein fluorescence and structural toolkit: Database and programs for the analysis of protein fluorescence and structural data. Proteins. 2008, 71(4), 1744-54. PubMed
Zoonens M, Reshetnyak YK, Engelman DM. Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors. Biophys J. 2008, 95(1), 225-35. PubMed
2007
Andreev OA, Dupuy AD, Segala M, Sandugu S, Serra DA, Chichester CO, Engelman DM, Reshetnyak YK. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci U S A. 2007, 104(19), 7893-8. PubMed
Andreev OA, Reshetnyak YK. Mechanism of formation of actomyosin interface. J Mol Biol. 2007, 365(3), 551-4. PubMed
Reshetnyak YK, Segala M, Andreev OA, Engelman DM. A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers. Biophys J. 2007, 93(7), 2363-72. PubMed
Torrent M, Cuyás E, Carreras E, Navarro S, López O, de la Maza A, Nogués MV, Reshetnyak YK, Boix E. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein. Biochemistry. 2007, 46(3), 720-33. PubMed
2006
Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc Natl Acad Sci U S A. 2006, 103(17), 6460-5. PubMed
Reshetnyak Y, Tchedre KT, Nair MP, Pritchard PH, Lacko AG. Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase. J Biomol Struct Dyn. 2006, 24(1), 75-82. PubMed
2004
Linke D, Frank J, Pope MS, Soll J, Ilkavets I, Fromme P, Burstein EA, Reshetnyak YK, Emelyanenko VI. Folding kinetics and structure of OEP16. Biophys J. 2004, 86(3), 1479-87. PubMed
Reshetnyak YK, Kitson RP, Lu M, Goldfarb RH. Conformational and enzymatic changes of 20S proteasome of rat natural killer cells induced by mono- and divalent cations. J Struct Biol. 2004, 145(3), 263-71. PubMed